2,135
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluating the Sensitivity, Specificity, and Accuracy of ChatGPT-3.5, ChatGPT-4, Bing AI, and Bard Against Conventional Drug-Drug Interactions Clinical Tools

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 137-147 | Received 11 Jul 2023, Accepted 09 Sep 2023, Published online: 20 Sep 2023

References

  • Mhlanga D. Open AI in education, the responsible and ethical use of ChatGPT towards lifelong learning. Education, the Responsible and Ethical Use of ChatGPT Towards Lifelong Learning (February 11, 2023); 2023.
  • Vaishya R, Misra A, Vaish A. ChatGPT: is this version good for healthcare and research? Diabetes Metab Syndr. 2023;17(4):102744. doi:10.1016/j.dsx.2023.102744
  • Hauben M. Artificial intelligence and data mining for the pharmacovigilance of drug–drug interactions. Clin Ther. 2023;45(2):117–133. doi:10.1016/j.clinthera.2023.01.002
  • Haluza D, Jungwirth D. Artificial intelligence and ten societal megatrends: an exploratory study using GPT-3. Systems. 2023;11(3):120. doi:10.3390/systems11030120
  • Jain S, Naicker D, Raj R, et al. Computational intelligence in cancer diagnostics: a contemporary review of smart phone apps, current problems, and future research potentials. Diagnostics. 2023;13(9):1563. doi:10.3390/diagnostics13091563
  • Kriger-Sharabi OA, Kopylov U. Harnessing the power of precision medicine and novel biomarkers to treat Crohn’s disease. J Clin Med. 2023;12(7):2696. doi:10.3390/jcm12072696
  • Khan O, Parvez M, Kumari P, Parvez S, Ahmad S. The future of pharmacy: how AI is revolutionizing the industry. Intell Pharm. 2023;1(1):32–40. doi:10.1016/j.ipha.2023.04.008
  • Bays HE, Fitch A, Cuda S, et al. Artificial intelligence and obesity management: an Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Obes Pillars. 2023;6:100065. doi:10.1016/j.obpill.2023.100065
  • Liu L, Duffy VG. Exploring the future development of Artificial Intelligence (AI) applications in chatbots: a bibliometric analysis. Int J Soc Robot. 2023; 2023:1–14.
  • Cabreja-Castillo M, Hernandez L, Mustafa A, Hungria G, Bertoli MT. COVID-19 scientific literacy in medical and nursing students. J Microbiol Biol Educ. 2023;24(1):e00219–00222. doi:10.1128/jmbe.00219-22
  • Rivas P, Zhao L. Marketing with chatgpt: navigating the ethical terrain of gpt-based chatbot technology. AI. 2023;4(2):375–384. doi:10.3390/ai4020019
  • Giansanti D. The chatbots are invading us: a map point on the evolution, applications, opportunities, and emerging problems in the health domain. Life. 2023;13(5):1130. doi:10.3390/life13051130
  • Hammour KA, Farha RA, Ya’acoub R, Salman Z, Basheti I. Impact of pharmacist-directed medication reconciliation in reducing medication discrepancies: a randomized controlled trial. Can J Hosp Pharm. 2022;2022:1.
  • Bossaer JB, Eskens D, Gardner A. Sensitivity and specificity of drug interaction databases to detect interactions with recently approved oral antineoplastics. J Oncol Pharm Pract. 2022;28(1):82–86. doi:10.1177/1078155220984244
  • Rossing P, Caramori ML, Chan JC, et al. Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence. Kidney Int. 2022;102(5):990–999. doi:10.1016/j.kint.2022.06.013
  • Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79(17):e263–e421. doi:10.1016/j.jacc.2021.12.012
  • Fleet JL, Shariff SZ, Bailey DG, et al. Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions. BMJ open. 2013;3(7):e002857. doi:10.1136/bmjopen-2013-002857
  • Sallam M. ChatGPT utility in healthcare education, research, and practice: systematic review on the promising perspectives and valid concerns. Healthcare. 2023;11(6):887. doi:10.3390/healthcare11060887
  • Juhi A, Pipil N, Santra S, Mondal S, Behera JK, Mondal H. The capability of ChatGPT in predicting and explaining common drug-drug interactions. Cureus. 2023;15(3):e36272. doi:10.7759/cureus.36272
  • Kung TH, Cheatham M, Medenilla A, et al. Performance of ChatGPT on USMLE: potential for AI-assisted medical education using large language models. PLOS Digit Health. 2023;2(2):e0000198. doi:10.1371/journal.pdig.0000198
  • Raimondi R, Tzoumas N, Salisbury T, et al. Comparative analysis of large language models in the Royal College of Ophthalmologists fellowship exams. Eye. 2023. doi:10.1038/s41433-023-02563-3
  • Gilson A, Safranek CW, Huang T, et al. How does ChatGPT perform on the United States medical licensing examination? The implications of large language models for medical education and knowledge assessment. JMIR Med Educ. 2023;9:e45312. doi:10.2196/45312
  • Das D, Kumar N, Longjam LA, et al. Assessing the capability of ChatGPT in answering first- and second-order knowledge questions on microbiology as per competency-based medical education curriculum. Cureus. 2023;15(3):e36034. doi:10.7759/cureus.36034
  • Jin D, Pan E, Oufattole N, Weng W-H, Fang H, Szolovits P. What disease does this patient have? A large-scale open domain question answering dataset from medical exams. Appl Sci. 2021;11(14):6421. doi:10.3390/app11146421
  • Liévin V, Hother CE, Winther OJ. Can large language models reason about medical questions?; 2022.
  • Yang X, Chen A, PourNejatian N, et al. A large language model for electronic health records. NPJ Digit Med. 2022;5(1):194. doi:10.1038/s41746-022-00742-2
  • Steinberg E, Jung K, Fries JA, Corbin CK, Pfohl SR, Shah NH. Language models are an effective representation learning technique for electronic health record data. J Biomed Inform. 2021;113:103637. doi:10.1016/j.jbi.2020.103637
  • Tiu E, Talius E, Patel P, Langlotz CP, Ng AY, Rajpurkar P. Expert-level detection of pathologies from unannotated chest X-ray images via self-supervised learning. Nat Biomed Eng. 2022;6(12):1399–1406. doi:10.1038/s41551-022-00936-9
  • Food and Drug Administration. Artificial intelligence and machine learning (AI/ML)-enabled medical devices. Food and Drug Administration; 2023. Available from: https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices. Accessed September 12, 2023.
  • Acosta JN, Falcone GJ, Rajpurkar P, Topol EJ. Multimodal biomedical AI. Nat Med. 2022;28(9):1773–1784. doi:10.1038/s41591-022-01981-2